AdBio Partners

Company Website
AdBio Partners
Other Services Classification
Anna Crespo

AGC Pharma Chemicals

Company Description

Global CDMO for Small Molecule API. AGC Pharma Chemicals, based in Barcelona and Japan, is a company specializing in the development and contract manufacturing of Active Pharmaceutical Ingredients, Small Molecule APIs, and advanced intermediates. We are part of the AGC Group, headquartered in Japan, and we offer an integrated supply chain, with globally coordinated capabilities in Europe and Asia, combined with a strong local presence in Barcelona. This structure allows us to ensure continuity, reliability, and long-term alignment with the needs of our pharmaceutical clients and support projects from the early development stages through to commercial production.

Product Developer Classification
Scientific Services Classification
Marta Bergada Escoda
LinkedIn logo Associate Director Business Development 
Partnership Goal

AGC Pharma Chemicals serves solutions for Big, mid-size and small Pharmaceutical companies; as well as Biotechs

AIR LIQUIDE

Company Description

Air Liquide es una empresa multinacional francesa, líder mundial en gases, tecnologías y servicios para la industria y la salud. Suministra soluciones esenciales como oxígeno, nitrógeno, dióxido de carbono e hidrógeno a sectores industriales que van desde la siderurgia hasta la industria alimentaria y pharmaceutica cumpliendo con las altas regulaciones de calidad que estos dos sectores implican.

Además, destaca por su enfoque en la innovación y la transición energética.

Javier Anglada Celades
LinkedIn logo Business Developer 
Partnership Goal

Networking con empresas del sector farmaceutico y biotecnologico en lo referente al suministro de gases para su producción, laboratorio y servicios asociados a su mantenimiento.

Partnership con empresas de consultoria e ingenieria.

Siguiendo la tendencia al alza del sector farmacéutico, en los últimos años hemos desarrollado nuevos productos y ofertas orientados a este mercado, que nos posicionan como una empresa diferenciadora en temas de calidad, producción, distribución y soporte técnico. 
Entre las principales aplicaciones sobre las que podríamos ampliarles información se encuentran: * Liofilización (refrigeración e inertización). * Sustitución de Gas Natural por H2 en Calderas (Hasta 20%, generando un 8% de reducción de emisiones de CO2). * Tratamiento de Aguas. * Phargalis Smart Quality. * EcoOrigin para LIN, LOX, LAR, CO2. * Recuperación de VoC's. * Intercambiador de calor.
Maria Jose Basagoiti
LinkedIn logo Quality & Compliance Manager 
Partnership Goal

Networking con empresas del sector farmaceutico y biotecnologico en lo referente al suministro de gases para su producción, laboratorio y servicios asociados a su mantenimiento.

Partnership con empresas de consultoria e ingenieria.

Siguiendo la tendencia al alza del sector farmacéutico, en los últimos años hemos desarrollado nuevos productos y ofertas orientados a este mercado, que nos posicionan como una empresa diferenciadora en temas de calidad, producción, distribución y soporte técnico. 
Entre las principales aplicaciones sobre las que podríamos ampliarles información se encuentran: * Liofilización (refrigeración e inertización). * Sustitución de Gas Natural por H2 en Calderas (Hasta 20%, generando un 8% de reducción de emisiones de CO2). * Tratamiento de Aguas. * Phargalis Smart Quality. * EcoOrigin para LIN, LOX, LAR, CO2. * Recuperación de VoC's. * Intercambiador de calor.

allpriv

Company Website
https://www.allpriv.com
Company Description

Allpriv OFFER the mandatory Cybersecurity layer to Medical Device Manufacturers, to only 20 first selected companies

Product Developer Classification
Miquel LEAL
Miquel LEAL
LinkedIn logo Ceo 
Partnership Goal

Allpriv OFFER to Medical Device Manufacturers the Mandatory Cyber layer, and look for visionary investors to disrupt the market

Georgina Cánovas
Georgina Cánovas
Marketing 
Partnership Goal

We OFFER Cyber-Brick to Medical Devices, and Investors to support this ambitious project

AMIDA 4

Company Website
www.amida4.com
Company Description

AMIDA|4 transforms innovation into production-ready solutions for the pharmaceutical and biotechnology industries.

We design and manufacture custom equipment for both laboratory and industrial environments, ensuring efficiency, safety, and reliability in regulated settings.

As hardware and software integrators, we implement advanced automation, control, and monitoring technologies to optimize processes, machinery, and facilities.

We incorporate quality control and data management systems to ensure robust, traceable processes compliant with GMP and 21 CFR Part 11.

We analyze each project in detail to select the most suitable technologies, turning innovation into scalable, validated processes ready for production.

-------- CATALÀ --------

AMIDA|4 transforma innovació en solucions productives per a la indústria farmacèutica i biotecnològica.

Dissenyem i fabriquem equips a mida, tant de laboratori com industrials, orientats a garantir eficiència, seguretat i fiabilitat en entorns regulats.

Com a integradors de hardware i software, implementem tecnologies avançades d’automatització, control i supervisió per optimitzar processos, maquinària i instal·lacions.

Incorporem sistemes de control de qualitat i gestió de dades que asseguren processos robustos, traçables i conformes amb GMP i 21 CFR Part 11.

Analitzem cada projecte amb detall per seleccionar les tecnologies més adequades i convertir la innovació en processos escalables, validats i preparats per producció.

Joaquim Torras
Joaquim Torras
LinkedIn logo BDM 
Partnership Goal

Open to strategic partnerships to bring regulated innovations from concept to scalable production

Joan Bagó
Joan Bagó
LinkedIn logo CEO 
Partnership Goal

Seeking strategic partnerships to industrialize and scale regulated innovations in pharma and biotech environments

Toni Medina
Toni Medina
LinkedIn logo CTO 
Partnership Goal

Partnering to accelerate the industrialization of validated technologies in regulated life science environments

AMS BIOPHARMA

Company Website
www.amsbiopharma.com
Company Description

AMSbiopharma is an analytical CRO devoted to providing Bioanalytical and CMC services for the Life Science industry throughout the entire product life cycle, from Research & Development to Product Manufacturing and Commercialization.

We provide services to clients worldwide in the pharmaceutical, biopharmaceutical, biotechnology, fine chemistry, medical cannabis, cosmeceutical and nutraceutical industries.

Things that make us a reliable and top quality CMC service provider:

- Our laboratory works under GLP/GMP following the latest EMA and FDA guidelines. Additionally we possess ISO certification such as 9001 & 140001

- We cover a broad spectrum of target molecules: Small molecules, Nitrosamines, Biomolecules (Hormones, Cannabinoids, Aminoacids, Peptides, Proteins, mABs, ADCs, Plasmids, Oligonucleotides), Heavy Metals, and many more depending on the clients' needs.

- We can do fully-customizable analytical studies related to: Vaccines, HCPs, Cell&Gene Therapies, Extractables & Leachables, Residuals Testing, Peptide Mapping, Metabolomics, Proteomics and In-vitro/In-vivo testing. We support stability studies as well.

- One of our biggest strength relies on our direct-to-expert approach and fast response time: up to 7 days after sample arrival for Routine QC validated methods, and up to 2 months for Method Development and Validation.

Tell us about your current challenges and ongoing projects. We can help you make it through.

We Looking forward to seeing you at the event

Scientific Services Classification
Samuel García del Blanco
LinkedIn logo Business Development Manager 
Partnership Goal

Certified CRO & Analytical Laboratory experts in nitrosamine testing, impurity profiling, QC/QA, elemental impurities, microbiological control, stability studies and much more. We operate with APIs, raw materials, excipients, drug substances and finished products.

  • QC & R&D Certified Testing Partner
  • Analytical Services & Consultancy
  • Chromatographic Method Development
  • Method Validation & Transfer
  • HPLC/UPLC-MS-MS
  • HPLC/UPLC-QTOF
  • Nitrosamines and impurity profiling
  • Stability Studies

AnaPath Research

Company Description

As a Global Science Provider, AnaPath specializes in high end histopathology and preclinical services, designed to support biotech and pharma companies seeking robust, expert driven development pathways. Our mission is to provide the scientific depth and personalized attention that innovative programs require.
AnaPath operates through two complementary European sites:
• Liestal, Switzerland – Our pathology institute and center of excellence for specialized scientific advice. With seven board certified pathologists, we deliver primary histopathology readouts, peer reviews, histomorphometry, immunofluorescence, RNAscope, microCT, laser microdissection, SEM/EDX, TEM, and more—covering early discovery up to fully regulatory studies.
• Barcelona, Spain – A GLP certified, AAALAC accredited facility equipped for high capacity study execution under strict OECD compliance. Our teams run studies across rodents, dogs, minipigs, and NHP, and provide comprehensive bioanalytical support for biologics, NCEs, and biomarkers throughout preclinical and clinical phases.
Our vision is to act as your long term scientific partner. We fly higher by providing deep pathology expertise tailored to complex programs such as medical devices, toxicology, and ATMPs.

Scientific Services Classification
Laura Rocamora
LinkedIn logo Head of Immunology&Molecular Biology department 
Partnership Goal

AnaPath is a Global Science Provider dedicated to accelerating preclinical drug development through high-end histopathology and specialized expertise. Our goal is to act as a reliable scientific extension that seamlessly complements CRO capabilities and reinforces Biotech development strategies from discovery to the regulatory stage. We seek synergistic collaborations to strengthen pipelines and elevate the scientific value of every project, driven by an uncompromising commitment to excellence. 

Bibiana Prades
Head of toxicology 
Partnership Goal

AnaPath is a Global Science Provider dedicated to accelerating preclinical drug development through high-end histopathology and specialized expertise. Our goal is to act as a reliable scientific extension that seamlessly complements CRO capabilities and reinforces Biotech development strategies from discovery to the regulatory stage. We seek synergistic collaborations to strengthen pipelines and elevate the scientific value of every project, driven by an uncompromising commitment to excellence. 

Anapharm Bioanalytics

Company Description

Anapharm Bioanalytics is a bioanalytical CRO supporting pharmaceutical and biotechnology companies across preclinical and clinical development (Phase I–III).

We provide high-quality, regulatory-compliant bioanalysis for both small and large molecules, including LC-MS/MS and ligand-binding assays (ELISA, MSD), as well as qPCR for gene therapy applications. Our capabilities cover pharmacokinetics (PK), immunogenicity (ADA/NAb), pharmacodynamics (PD), and biomarker analysis.

With extensive experience in regulated environments (GLP, GCP) and a strong focus on scientific rigor, project management, and client communication, Anapharm acts as a reliable partner for complex bioanalytical challenges.

Scientific Services Classification
Robert Fontarnau
LinkedIn logo Director Business Development 
Partnership Goal

We are looking to connect with biotech and pharmaceutical companies developing new therapeutics across preclinical and clinical stages, particularly those approaching IND-enabling studies or early clinical development.

Our goal is to explore how we can support bioanalytical needs, including PK, immunogenicity, biomarkers, and central lab activities, and to build long-term collaborations.

We are also open to connecting with CROs, CDMOs, and other service providers to identify complementary capabilities and potential partnership opportunities.

Archivel Farma

Company Description

Archivel is a CDMO specializaed in Aseptic fill-finish and lyophilization for clinical-stage drug products. Our company is built on 20 years of experience delivering life-saving treatments to patients worldwide. 

We support programs from research through Phase II — manufacturing GMP and non-GMP lots for biotech companies and translational researchers who need a specialist partner with the technical depth and regulatory readiness that complex biologics demand

Other Services Classification
Nerea Capón Lamelas
Nerea Capón Lamelas
LinkedIn logo Business Development Manager 

ARVOR

Company Website
www.arvor.es
Company Description

We are a consulting firm specialized in business development and technology transfer based on research, technology, and innovation. We carry out market studies, business plans, roadmaps, customer discovery, training and mentoring, as well as valuation and the search for licensees. We cover the entire biotechnology and healthcare sector, including drug development, medical devices, diagnostic methods, and nutritional supplementation, among others.

Oscar Rey Puiggros
LinkedIn logo Partner 
Partnership Goal

We are interested in meeting with startups and academic groups that need support in positioning themselves to transfer their technology in the future, whether they require a clear roadmap, need to find licensees or investors, develop a business plan or market study, or are looking for mentors. We work with projects ranging from early TRL stages to those that are close to market readiness.